RecruitingNCT05179616

Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair

Pforzheim Tricuspid Valve Registry: A Real-world Observational Trial Evaluating Outcomes in Patients Treated With the Abbott TriClip™ Device in Helios Klinikum Pforzheim

Sponsor

Helios Klinikum Pforzheim

Enrollment

200 participants

Start Date

Nov 30, 2020

Study Type

OBSERVATIONAL

Conditions

Tricuspid Regurgitation Right Heart Failure Cardiac Remodeling, Ventricular Cardiac Remodeling, Atrial

Summary

The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This registry is tracking outcomes for patients who have had a minimally invasive procedure to repair a leaky tricuspid valve in the heart (the valve on the right side) using a device called TriClip, which is inserted via a catheter rather than open-heart surgery. **You may be eligible if:** - You are 18 years or older - You have been diagnosed with severe tricuspid regurgitation (a very leaky tricuspid heart valve) - You still have symptoms despite taking medications - You are eligible to receive the TriClip device - You are able to give written informed consent **You may NOT be eligible if:** - You are currently enrolled in another clinical study that might interfere with the results of this registry Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.